Portside Wealth Group, LLC Tg Therapeutics, Inc. Put Options Transaction History
Portside Wealth Group, LLC
- $744 Billion
- Q4 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TGTX
# of Institutions
397Shares Held
92.8MCall Options Held
1.77MPut Options Held
1.9M-
Vanguard Group Inc Valley Forge, PA15.8MShares$491 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$353 Million0.0% of portfolio
-
State Street Corp Boston, MA8.1MShares$251 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY4.64MShares$144 Million0.13% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.84MShares$119 Million8.45% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.5B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...